What does CUSIP 76155X100 represent in this 13F holders report?

CUSIP 76155X100 is the security identifier for RVMD - Revolution Medicines, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RVMD - Revolution Medicines, Inc. - Common Stock in Q2 2023?

138 institutional investors reported RVMD - Revolution Medicines, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Revolution Medicines, Inc. - Common Stock (RVMD)

CUSIP: 76155X100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 199,316,245
Total 13F shares: 111,960,439
Share change: +3,736,791
Total reported value: $2,994,417,481
Put/Call ratio: 40%
Price per share: $26.75
Number of holders: 138
Value change: +$107,072,959
Number of buys: 69
Number of sells: 64

Quarterly Holders Quick Answers

What is CUSIP 76155X100?
CUSIP 76155X100 identifies RVMD - Revolution Medicines, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 76155X100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.2%	10,425,368	$225,813,473	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.7%	9,302,553	$201,493,299	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	3.7%	7,465,774	$161,708,665	—	31 Mar 2023	13F
Third Rock Ventures III, L.P.	3/4/5	10%+ Owner	— class O/S missing	5,104,130	$137,811,510	—	08 Jun 2022	3/4/5
EcoR1 Capital, LLC	13F	Company	2.7%	5,352,183	$115,928,284	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.5%	5,035,179	$109,063,000	—	31 Mar 2023	13F
BVF INC/IL	13F	Company	2.5%	4,955,588	$107,338,036	—	31 Mar 2023	13F
Nextech Invest Ltd.	13F	Company	2.4%	4,839,529	$104,824,198	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.4%	4,811,431	$104,215,595	—	31 Mar 2023	13F
Bellevue Group AG	13F	Company	2.4%	4,747,900	$102,839,514	—	31 Mar 2023	13F
Boxer Capital, LLC	13F	Company	2.4%	4,684,264	$101,461,000	—	31 Mar 2023	13F
Column Group LLC	13F	Company	2.3%	4,577,840	$99,156,014	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	1.7%	3,422,972	$74,141,574	—	31 Mar 2023	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.6%	3,283,600	$71,122,776	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	1.6%	3,262,638	$70,669,000	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	1.4%	2,691,493	$58,297,738	—	31 Mar 2023	13F
Holocene Advisors, LP	13F	Company	1.1%	2,104,818	$45,590,358	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	1%	2,070,988	$44,858,000	—	31 Mar 2023	13F
Casdin Capital, LLC	13F	Company	0.91%	1,810,000	$39,204,600	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.87%	1,734,077	$37,560,123	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.81%	1,609,987	$34,871,778	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	0.67%	1,344,800	$29,128,368	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.57%	1,136,058	$24,607,016	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.56%	1,123,958	$24,344,929	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.47%	941,733	$20,397,937	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.43%	854,484	$18,508,123	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.42%	829,737	$17,972,103	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.39%	785,557	$17,015,164	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	0.35%	702,712	$15,220,742	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	657,227	$14,235,537	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.3%	598,671	$12,967,214	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.29%	575,785	$12,471,503	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.3%	606,332	$12,088,176	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	553,051	$11,979,000	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.26%	514,016	$11,133,587	—	31 Mar 2023	13F
BESSEMER GROUP INC	13F	Company	0.22%	442,442	$9,583,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.19%	384,737	$8,333,403	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.19%	376,450	$8,153,907	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.18%	352,828	$7,635,208	—	31 Mar 2023	13F
Integral Health Asset Management, LLC	13F	Company	0.17%	345,000	$7,472,700	—	31 Mar 2023	13F
Mass General Brigham, Inc	13F	Company	0.17%	338,191	$7,325,000	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.16%	327,586	$7,095,513	—	31 Mar 2023	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.16%	315,550	$6,834,813	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	306,823	$6,645,786	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.15%	292,611	$6,337,954	—	31 Mar 2023	13F
Polar Asset Management Partners Inc.	13F	Company	0.14%	280,000	$6,064,800	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.13%	263,768	$5,713,215	—	31 Mar 2023	13F
MPM BioImpact LLC	13F	Company	0.12%	247,022	$5,350,497	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	238,821	$5,172,000	—	31 Mar 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.11%	210,768	$4,565,235	—	31 Mar 2023	13F

Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q2 2023

As of 30 Jun 2023, Revolution Medicines, Inc. - Common Stock (RVMD) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 111,960,439 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, BVF INC/IL, PRICE T ROWE ASSOCIATES INC /MD/, Nextech Invest Ltd., Bellevue Group AG, STATE STREET CORP, and Boxer Capital, LLC. This page lists 138 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

149

Q2 2023 holders

138

Holder diff

-11

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.